NCT00719277
Unknown
Not Applicable
Pilot Clinical Study of the Sleuth Implantable ECG Monitoring System
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Arrhythmia
- Sponsor
- Transoma Medical
- Enrollment
- 40
- Locations
- 1
- Primary Endpoint
- Diagnostically viable ECG signals
- Last Updated
- 17 years ago
Overview
Brief Summary
The purpose of the study is to evaluate the safety and performance of the Sleuth Monitoring system.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Age \> = 18 years at time of enrollment
- •Either of the following:
- •MI \> 30 days prior to enrolment and LVEF \< = 35% by echocardiography (or nuclear imaging as necessary)
- •Syncope of unknown etiology
Exclusion Criteria
- •Life expectancy \< 12 months following enrollment
- •Active infection
Outcomes
Primary Outcomes
Diagnostically viable ECG signals
Time Frame: daily
Secondary Outcomes
- rate of device-related adverse events(1, 6, and 12 months)
Study Sites (1)
Loading locations...
Similar Trials
Unknown
Not Applicable
Observational Study of the Sleuth Implantable ECG Monitoring SystemSyncopePresyncopeFaintingCardiac ArrhythmiaNCT00717106Transoma Medical250
Completed
Not Applicable
BIO.MASTER.BioMonitor 2 StudyTachyarrhythmiaAtrial FibrillationSyncopeNCT02565238Biotronik SE & Co. KG92
Recruiting
Early Phase 1
Interstage Monitoring Using an Implantable Loop Recorder: A Pilot StudyUniventricular HeartNCT05744934Boston Children's Hospital10
Completed
Not Applicable
Study of New Implantable Loop RecorderTachyarrhythmiasSyncopeNCT00746564Abbott Medical Devices75
Recruiting
Early Phase 1
Implantable Microdevice In Primary Brain TumorsGrade II GliomaGrade III GliomaGrade IV GliomaAstrocytomaOligodendroglioma of BrainAnaplastic Astrocytoma of BrainAnaplastic OligodendrogliomaGlioblastomaNCT04135807Oliver Jonas12